BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23850219)

  • 1. [Compassionate use of intrathecal ketamine for intractable cancer pain].
    Mion G; Marchetti F; Samama CM
    Ann Fr Anesth Reanim; 2013 Sep; 32(9):621-2. PubMed ID: 23850219
    [No Abstract]   [Full Text] [Related]  

  • 2. Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain.
    Mercadante S; Villari P; Ferrera P; Arcuri E
    Anesth Analg; 2004 Feb; 98(2):557-558. PubMed ID: 14742416
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketamine for pain: an update of uses in palliative care.
    Prommer EE
    J Palliat Med; 2012 Apr; 15(4):474-83. PubMed ID: 22500483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal S(+)-ketamine in refractory neuropathic cancer pain.
    Kozek SA; Sator-Katzenschlager S; Kress HG
    Pain; 2006 Apr; 121(3):283-284. PubMed ID: 16513276
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine*.
    Quibell R; Prommer EE; Mihalyo M; Twycross R; Wilcock A
    J Pain Symptom Manage; 2011 Mar; 41(3):640-9. PubMed ID: 21419322
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients.
    Marchetti F; Coutaux A; Bellanger A; Magneux C; Bourgeois P; Mion G
    Eur J Pain; 2015 Aug; 19(7):984-93. PubMed ID: 25381898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effect of intravenous ATP on postherpetic neuralgia in comparison with responses to intravenous ketamine and lidocaine.
    Hayashida M; Fukuda K; Fukunaga A; Meno A; Sato K; Tarui K; Arita H; Kaneko Y; Hanaoka K
    J Anesth; 2005; 19(1):31-5. PubMed ID: 15674513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subanesthetic ketamine for cancer pain: by insisting on level I/II evidence, do we risk throwing the baby out with the bath water?
    Jackson K; Ashby M; Goodchild C
    J Pain Symptom Manage; 2005 Apr; 29(4):328-30. PubMed ID: 15857732
    [No Abstract]   [Full Text] [Related]  

  • 9. Low-dose ketamine as a potential adjuvant therapy for painful vaso-occlusive crises in sickle cell disease.
    Neri CM; Pestieau SR; Darbari DS
    Paediatr Anaesth; 2013 Aug; 23(8):684-9. PubMed ID: 23565738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infra-anesthetic ketamine dosage in the treatment of neuropathic-type pain].
    Mion G; Rüttimann M; Daniel L
    Ann Fr Anesth Reanim; 1997; 16(1):81-2. PubMed ID: 9686111
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of ketamine in complex regional pain syndrome: possible mechanisms.
    Schwartzman RJ; Alexander GM; Grothusen JR
    Expert Rev Neurother; 2011 May; 11(5):719-34. PubMed ID: 21539489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine use in palliative care #132.
    Prommer E
    J Palliat Med; 2010 Nov; 13(11):1381-2. PubMed ID: 21091023
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine and ketamine for sedation during spinal anesthesia in children.
    McVey JD; Tobias JD
    J Clin Anesth; 2010 Nov; 22(7):538-45. PubMed ID: 21056811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance.
    Sator-Katzenschlager S; Deusch E; Maier P; Spacek A; Kress HG
    Anesth Analg; 2001 Oct; 93(4):1032-4, table of contents. PubMed ID: 11574378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The addition of ketamine to a morphine nurse- or patient-controlled analgesia infusion (PCA/NCA) increases analgesic efficacy in children with mucositis pain.
    James PJ; Howard RF; Williams DG
    Paediatr Anaesth; 2010 Sep; 20(9):805-11. PubMed ID: 20716072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of continuous intravenous ketamine for end-stage cancer pain in children.
    Conway M; White N; Jean CS; Zempsky WT; Steven K
    J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subanesthetic ketamine: an essential adjuvant for intractable cancer pain.
    Kotlińska-Lemieszek A; Luczak J
    J Pain Symptom Manage; 2004 Aug; 28(2):100-2. PubMed ID: 15276189
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain.
    Benrath J; Scharbert G; Gustorff B; Adams HA; Kress HG
    Br J Anaesth; 2005 Aug; 95(2):247-9. PubMed ID: 15951328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization.
    Maher DP; Chen L; Mao J
    Anesth Analg; 2017 Feb; 124(2):661-674. PubMed ID: 28067704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.